By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

PTC Therapeutics, Inc. 

100 Corporate Court

South Plainfield  New Jersey  07080-2449  U.S.A.
Phone: 908-222-7000 Fax: 908-222-7231


SEARCH JOBS



Segment
Drug Discovery





Company News
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/11/2017 11:33:31 AM
Former PTC Therapeutics (PTCT) Exec Jumps Ship to Orchard Therapeutics as CEO 8/10/2017 6:06:20 AM
PTC Therapeutics (PTCT) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/9/2017 12:18:16 PM
PTC Therapeutics (PTCT) To Host Conference Call To Discuss Second Quarter Financial Results 7/25/2017 11:46:07 AM
PTC Therapeutics (PTCT) Announces Promotion Of Dr. Joseph Mcintosh To Senior Vice President And Head Of Clinical Development 7/25/2017 7:36:29 AM
PTC Therapeutics (PTCT) Announces Publication Of Data From ACT DMD In The Lancet 7/18/2017 8:03:21 AM
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7/5/2017 8:24:22 AM
PTC Therapeutics (PTCT) Release: Preliminary Phase II Data From Spinal Muscular Atrophy Program Presented At CureSMA Conference 7/5/2017 6:39:06 AM
PTC Therapeutics (PTCT) Release: New Analyses of Translarna (Ataluren) Data From ACT DMD Presented At The 12th Annual European Pediatric Neurology Society Congress 6/22/2017 7:32:41 AM
PTC Therapeutics (PTCT) Announces FDA Advisory Committee Meeting For Ataluren For The Treatment Of Nonsense Mutation Dystrophinopathy 6/6/2017 10:47:14 AM
12345678910...
//-->